Hazra, Moumita. 2019. “A Rational Pharmacotherapeutic Study of Comparative Safety Among Topical Anti-Acne 1% Nadifloxacin Monotherapy, 0.1% Adapalene Monotherapy, 0.025% Tretinoin Monotherapy, 1% Nadifloxacin and 0.1% Adapalene Combination Therapy and 1% Nadifloxacin and 0.025% Tretinoin Combination Therapy, in Mild to Moderate Acne Vulgaris, in Tertiary Care Hospitals”. International Journal of Basic & Clinical Pharmacology 8 (9):1959-65. https://doi.org/10.18203/2319-2003.ijbcp20193662.